Increased VWF has been implicated in vascular dysfunction [46] and decreased UBE2T in Fanconi anemia [47], and acute deregulated expression of these genes may have contributed to the adverse outcomes observed within 2 weeks of Zeb1/2 deletion. This evidence concerns the gene ZEB1 and Fanconi anemia.